OPTIMAL SCHEDULE FOR 5-FLUOROURACIL CHEMOTHERAPY - INTERMITTENT BOLUS OR CONTINUOUS INFUSION

被引:36
|
作者
LOKICH, JJ
机构
关键词
D O I
10.1097/00000421-198510000-00019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:445 / 448
页数:4
相关论文
共 50 条
  • [1] PHARMACOKINETICS OF ARTERIAL INFUSION CHEMOTHERAPY - EXPERIMENTAL STUDIES ON OPTIMAL THERAPEUTIC SCHEDULE OF ARTERIAL INFUSION CHEMOTHERAPY WITH 5-FLUOROURACIL
    OTA, J
    FUJITA, M
    TAGUCHI, T
    [J]. CANCER CHEMOTHERAPY : CHALLENGES FOR THE FUTURE, VOL 4, 1989, 904 : 23 - 28
  • [2] THE 2 SIDES OF 5-FLUOROURACIL - BOLUS AND CONTINUOUS-INFUSION
    ASCHELE, C
    GUGLIELMI, A
    MORI, A
    TIXI, L
    BOLLI, E
    CIFERRI, E
    FAZIO, S
    MUNICINO, O
    SOBRERO, A
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1995, 14 (02) : 53 - 59
  • [3] Anaphylaxis following continuous 5-fluorouracil infusion chemotherapy
    Biswal, BM
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1999, 29 (05): : 743 - 744
  • [4] Continuous infusion of chemotherapy: focus on 5-fluorouracil and fluorodeoxyuridine
    Poorter, RL
    Bakker, PJM
    Veenhof, CHN
    [J]. PHARMACY WORLD & SCIENCE, 1998, 20 (02): : 45 - 59
  • [5] Effects of a bolus injection of 5-fluorouracil on dihydropyrimidine dehydrogenase activity in rats receiving continuous infusion of 5-fluorouracil
    Kobuchi, Shinji
    Hayashi, Asuka
    Taniguchi, Mayu
    Ito, Yukako
    Tamura, Takao
    Sakaeda, Toshiyuki
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (03) : 517 - 523
  • [6] Effects of a bolus injection of 5-fluorouracil on dihydropyrimidine dehydrogenase activity in rats receiving continuous infusion of 5-fluorouracil
    Shinji Kobuchi
    Asuka Hayashi
    Mayu Taniguchi
    Yukako Ito
    Takao Tamura
    Toshiyuki Sakaeda
    [J]. Cancer Chemotherapy and Pharmacology, 2016, 78 : 517 - 523
  • [7] CONTINUOUS-INFUSION CISPLATIN AND BOLUS 5-FLUOROURACIL IN COLORECTAL-CARCINOMA
    POSNER, MR
    BELLIVEAU, JF
    WEITBERG, AB
    SABBATH, K
    WIEMANN, MC
    CUMMINGS, FJ
    CALABRESI, P
    [J]. CANCER TREATMENT REPORTS, 1987, 71 (10): : 975 - 977
  • [8] ACTIVITY OF CONTINUOUS-INFUSION 5-FLUOROURACIL IN PATIENTS WITH ADVANCED COLORECTAL-CANCER CLINICALLY RESISTANT TO BOLUS 5-FLUOROURACIL
    MORI, A
    BERTOGLIO, S
    GUGLIELMI, A
    ASCHELE, C
    BOLLI, E
    TIXI, L
    ROSSO, R
    SOBRERO, A
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 33 (02) : 179 - 180
  • [9] Raltitrexed plus levofolinic acid and bolus/continuous infusion 5-fluorouracil on a biweekly schedule for elderly patients with advanced colorectal carcinomas
    Gebbia, V.
    Verderame, F.
    Ferrau, F.
    Bordonaro, R.
    Callari, A.
    Caruso, M.
    Tirrito, M. L.
    Valenza, R.
    Cicero, G.
    Borsellino, N.
    Tralongo, P.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : VII60 - VII65
  • [10] Intermittent continuous infusion of ifosfamide and 5-fluorouracil in patients with advanced adenocarcinoma of the pancreas
    Poorter, RL
    Bakker, PJM
    Huizing, MT
    Taat, CW
    Rietbroek, RC
    Gouma, DJ
    Rauws, EAJ
    Veenhof, CHN
    [J]. ANNALS OF ONCOLOGY, 1995, 6 (10) : 1048 - 1049